HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation

Abstract

Human Immunodeficiency virus (HIV) enters the brain soon after seroconversion and induces chronic neuroinflammation by infecting and activating brain macrophages. Inflammasomes are cytosolic protein complexes that mediate caspase-1 activation and ensuing cleavage and release of IL-1β and -18 by macrophages. Our group recently showed that HIV-1 infection of human microglia induced inflammasome activation in NLRP3-dependent manner. The HIV-1 viral protein R (Vpr) is an accessory protein that is released from HIV-infected cells, although its effects on neuroinflammation are undefined. Infection of human microglia with Vpr-deficient HIV-1 resulted in reduced caspase-1 activation and IL-1β production, compared to cells infected with a Vpr-encoding HIV-1 virus. Vpr was detected at low nanomolar concentrations in cerebrospinal fluid from HIV-infected patients and in supernatants from HIV-infected primary human microglia. Exposure of human macrophages to Vpr caused caspase-1 cleavage and IL-1β release with reduced cell viability, which was dependent on NLRP3 expression. Increased NLRP3, caspase-1, and IL-1β expression was evident in HIV-1 Vpr transgenic mice compared to wild-type littermates, following systemic immune stimulation. Treatment with the caspase-1 inhibitor, VX-765, suppressed NLRP3 expression with reduced IL-1β expression and associated neuroinflammation. Neurobehavioral deficits showed improvement in Vpr transgenic animals treated with VX-765. Thus, Vpr-induced NLRP3 inflammasome activation, which contributed to neuroinflammation and was abrogated by caspase-1 inhibition. This study provides a new therapeutic perspective for HIV-associated neuropsychiatric disease.

P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model

“…IL-1␤ plays a pivotal role in signaling of other inflammatory cytokines. Emerging evidence suggests a key role for the inflammasome in atherosclerotic disease progression (73)(74)(75)(76)(77)(78)(79)(80)(81)(82)(83) and in HIV-1 disease (47,(84)(85)(86)(87)(88)(89). Inflammasome activation requires two signals, one for priming (i.e., TLR signaling which results in transcriptional regulation) and then one for activation of inflammasome complex assembly.…”

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

“…Depending on its concentration in culture, insulin can enhance the secretion of certain inflammatory cytokines and inhibit the production of others. In addition, insulin has also demonstrated selective anti-inflammatory and antiviral actions in cultured human primary microglia from HIV-1-infected fetal tissue, as well as in cats infected with feline immunodeficiency virus 96 .…”

NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies

“…Interestingly, the expression of NLRP3 inflammasome-associated genes was also increased in the brains of patients with HIV/AIDS (Walsh et al, 2014). An in vivo model of feline immunodeficiency viral infection and HIV-1 Vpr transgenic mice exhibited NLRP3 inflammasome activation with accompanying neuronal loss and neurological disorders (Walsh et al, 2014; Mamik et al, 2016). …”